Association Between Hypnotics, Accidents, and Injuries: A Study Based on the Adverse Drug Event Reporting Database in Japan

被引：0

作者：

Sogawa, Rintaro ^{[1
]}

Hatano, Masakazu ^{[2
]}

Nishimura, Fumi ^{[1
]}

Nishi, Junya ^{[1
]}

Matsuoka, Ayaka ^{[3
]}

Shinada, Kota ^{[3
]}

Yamada, Haruna ^{[4
]}

Tateishi, Hiroshi ^{[5
]}

Mizoguchi, Yoshito ^{[5
]}

Monji, Akira ^{[6
]}

Shimanoe, Chisato ^{[1
]}

机构：

[1] Saga Univ Hosp, Dept Pharm, 5-1-1 Nabeshima, Saga 8498501, Japan

[2] Fujita Hlth Univ, Sch Med, Dept Pharmacotherapeut & Informat, Toyoake, Japan

[3] Saga Univ Hosp, Dept Emergency & Crit Care Med, Nabeshima, Japan

[4] Saga Univ, Inst Nursing, Fac Med, Nabeshima, Japan

[5] Saga Univ, Fac Med, Dept Psychiat, Nabeshima, Japan

[6] Wakahisa Hosp, Wakahisa, Japan

来源：

IN VIVO | 2025年 / 39卷 / 01期

关键词：

Accident; adverse drug event; hypnotics; injury; HIGHWAY DRIVING PERFORMANCE; ZOPICLONE; 7.5; MG; METAANALYSIS; MEDICATION; FALLS; RISK; PLACEBO;

D O I：

10.21873/invivo.13846

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Background/Aim: The use of hypnotic drugs can lead to accidents and injuries. However, few reports have shown their association with these events after adjusting for many concomitant medications. This study aimed to determine whether the use of hypnotic drugs was associated with accidents and injuries. Patients and Methods: Using the Japanese Adverse Event Reporting Database, 772,387 reports published between September 2023 and April 2004 were analyzed. Reporting odds ratios (RORs) and 95% confidence intervals (CIs) for accidents and injuries associated with each hypnotic drug were calculated after adjusting for potential confounders. Results: Of the total, 12,484 reports indicated association of hypnotic drugs with accidents and injuries. The use of each hypnotic drug was associated with accidents, injuries, and other adverse events. However, a multivariate analysis adjusted for age, sex, reporting year, and concomitant medications showed a considerable decrease in ROR for melatonin receptor agonists (adjusted ROR=1.26; 95%CI=1.03-1.55) and dual orexin receptor antagonists (DORAs) (adjusted ROR=1.04; 95%CI=0.86-1.25). Particularly in DORAs, a loss of signal for accidents and injuries was observed. Conclusion: The risk of accidents and injuries may vary with hypnotic drug use; however, DORAs may be less frequently associated with these events. The results of this study provide useful information for the selection of hypnotic drugs.

引用

页码：433 / 439

页数：7

共 50 条

[21] The safety of niacin in the US Food and Drug Administration Adverse Event Reporting database
Alsheikh-Ali, Alawi A.
Karas, Richard H.
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8A): : 9B - 13B
[22] Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
Morris, Robert
Ali, Rahinatu
Cheng, Feng
CURRENT DRUG TARGETS, 2024, 25 (07) : 454 - 464
[23] Adverse events of epidiolex: A real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database
Zhou, Qin
Du, Zhiqiang
Qu, Kankan
Shen, Yuan
Jiang, Ying
Zhu, Haohao
Zhang, Xiuhong
ASIAN JOURNAL OF PSYCHIATRY, 2023, 90
[24] Adverse events of nusinersen: a real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database
Zhang, Xiaofang
Gui, Jianxiong
Wang, Lingman
Jiang, Chunxue
Ding, Ran
Meng, Linxue
Hong, Siqi
Jiang, Li
EXPERT OPINION ON DRUG SAFETY, 2024,
[25] Adverse events of Capmatinib: A real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database
Zhang, Hao
Zhao, Panli
Huang, Hua
MEDICINE, 2025, 104 (05)
[26] Data Mining and Analysis for Iodinated Contrast Media Adverse Event Signals Based on the Food and Drug Administration Adverse Event Reporting System Database
Tan, Juntao
Yu, Yue
He, Yuxin
Zheng, Jiangyuan
Tan, Qingzhu
Zhang, Xiao
Wan, Chao
Zhang, Zhengyu
Wu, Xiaoxin
Tan, Rui
CLINICAL THERAPEUTICS, 2025, 47 (01) : 82 - 90
[27] A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
Wu, Bin
Hu, Qiaozhi
Tian, Fangyuan
Wu, Fengbo
Li, Yuwen
Xu, Ting
SCIENTIFIC REPORTS, 2021, 11 (01)
[28] A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
Bin Wu
Qiaozhi Hu
Fangyuan Tian
Fengbo Wu
Yuwen Li
Ting Xu
Scientific Reports, 11
[29] Risk of drug-induced angioedema: a pharmacovigilance study of FDA adverse event reporting system database
Fan, Maoxia
Niu, Kaibin
Wu, Xiaoqi
Shi, Hongshuo
FRONTIERS IN PHARMACOLOGY, 2024, 15
[30] Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database
Caldito, Natalia Gonzalez
Shirani, Afsaneh
Salter, Amber
Stuve, Olaf
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (07) : 1066 - 1076

← 1 2 3 4 5 →